Markets Review: RSA adds 59% in November global vaccine-led rally
Share’s in London-listed RSA gained almost 60 percent in November as UK and European stocks closed their best month in more than three decades, after a rally powered by Covid-19 vaccine breakthroughs.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below